首页|期刊导航|介入医学杂志（英文）|Sorafenib plus hepatic arterial infusion chemotherapy with oxaliplatin versus sorafenib alone for advanced hepatocellular carcinoma

Sorafenib plus hepatic arterial infusion chemotherapy with oxaliplatin versus sorafenib alone for advanced hepatocellular carcinoma

Yang Zhao JiaYing Lai RunBin Liang MinKe He Ming Shi

介入医学杂志（英文）2019，Vol.2Issue(2)：78-83,6.

Sorafenib plus hepatic arterial infusion chemotherapy with oxaliplatin versus sorafenib alone for advanced hepatocellular carcinoma

Yang Zhao ¹JiaYing Lai ²RunBin Liang ¹MinKe He ¹Ming Shi¹

作者信息

1. Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
2. HuiDong Senior Middle School, Huidong Huizhou, China
折叠

摘要

关键词

Hepatocellular carcinoma/Barcelona clinic liver cancer stage C/Sorafenib/Hepatic arterial infusion chemotherapy/Oxaliplatin

Key words

Hepatocellular carcinoma/Barcelona clinic liver cancer stage C/Sorafenib/Hepatic arterial infusion chemotherapy/Oxaliplatin

引用本文复制引用

Yang Zhao,JiaYing Lai,RunBin Liang,MinKe He,Ming Shi..Sorafenib plus hepatic arterial infusion chemotherapy with oxaliplatin versus sorafenib alone for advanced hepatocellular carcinoma[J].介入医学杂志（英文）,2019,2(2):78-83,6.

基金项目

This work was supported by National Key R&D Program of China (2017YFA0505803),National Natural Science Foundation of China (No.81625017,No.81572385),National Science and Technology Major Project of China (2018ZX10302205). （2017YFA0505803）

介入医学杂志（英文）

访问量0

下载量0

段落导航